// App-Quantinova.ai

1109-113 : NOAC BUT NOT VKA FAVORABLY AFFECT ENDOGENOUS THROMBOLYTIC STATUS: A NOVEL MECHANISM OF ACTION

Researchers

Presenter

  • Maria Niespialowska-Steuden

Principal Investigators

  • Osita Okafor

  • Peter Collins

  • Manivannan Srinivasan

  • Diana Adrienne Gorog

Medical Centers

  • Imperial College, London, United Kingdom

  • University of Hertfordshire, Hatfield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Arrhythmia

  • Renal insufficiency

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved